Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood
Sponsor: Boehringer Ingelheim
Summary
The main objective of this trial is to investigate the effects of multiple doses of Itraconazole and multiple doses of Ciclosporin on the pharmacokinetics of BI 3000202 in plasma following a single oral dose in healthy male trial participants.
Official title: The Effects of P-gp Inhibition and OATP Inhibition on the Pharmacokinetics of a Single Oral Dose of BI 3000202 in Healthy Male Trial Participants (an Open-label, Three-period, Two-sequence Crossover Trial, With Period 3 as Fixed Treatment)
Key Details
Gender
MALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2026-09-01
Completion Date
2026-10-26
Last Updated
2026-08-19
Healthy Volunteers
Yes
Conditions
Interventions
BI 3000202
BI 3000202
Ciclosporin
Ciclosporin
Itraconazole
Itraconazole
Locations (1)
Humanpharmakologisches Zentrum Biberach
Biberach, Germany